Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Mangoceuticals, Inc. ( (MGRX) ) has provided an announcement.
On October 27, 2025, Mangoceuticals, Inc. entered into a lease agreement for office space in Dallas, Texas, which includes a right of first refusal to purchase the premises. The lease, effective from November 1, 2025, to October 31, 2030, involves a monthly base rent and additional costs for taxes and maintenance. Additionally, the company finalized a separation agreement with its former COO, Amanda Hammer, effective October 22, 2025, which includes a separation payment over nine months and potential consulting opportunities. Furthermore, the company saw conversions of its Series B Convertible Preferred Stock into common stock by Indigo Capital LP and Platinum Point Capital, LLC in September and October 2025, respectively.
More about Mangoceuticals, Inc.
Average Trading Volume: 198,831
Technical Sentiment Signal: Sell
Current Market Cap: $21.81M
Find detailed analytics on MGRX stock on TipRanks’ Stock Analysis page.